Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia
Clinical trial NCT03198078 · COMPLETED
Trial details
- NCT number
- NCT03198078
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-30
- Primary completion
- 2023-04-03
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.